New approaches for estimation of effect sizes and their confidence intervals for treatment effects from randomized controlled trials

被引:18
|
作者
Feingold, Alan [1 ]
机构
[1] Oregon Social Learning Ctr, 207 E 5Th Ave Suite 202, Eugene, OR 97401 USA
来源
QUANTITATIVE METHODS FOR PSYCHOLOGY | 2019年 / 15卷 / 02期
基金
美国国家卫生研究院;
关键词
effect sizes; condence intervals; multilevel analysis; latent growth models; STANDARDIZED EFFECT SIZES; GROWTH; MULTILEVEL; MEDIATION; METAANALYSIS; MODELS;
D O I
10.20982/tqmp.15.2.p096
中图分类号
C [社会科学总论];
学科分类号
03 ; 0303 ;
摘要
Although Cohen's d and the growth modeling analysis (GMA) d from linear models are common standardized effect sizes used to convey treatment effects, popular statistical software packages do not include them in their standard outputs. This article demonstrated the use of statistical software with user-prescribed parameter functions (e.g., Mplus) to produce d for treatment effects from both classical analysis and GMA-along with their associated standard errors (SEs) and confidence intervals (CIs). A Monte Carlo study was conducted to examine bias in the SE and CI for GMA d obtained with Mplus and found that both estimates were more accurate when calculated by the software with the standard bootstrap than with the delta method, but the delta method estimates were less biased than respective estimates from extant post hoc equations. Thus, users of many statistical software packages (including SAS, R, and LISREL) should obtain d or GMA d and associated CIs directly. Researchers employing less versatile software-and meta-analysts including ds and GMA ds in their syntheses of treatment effects-should continue to use the conventional post hoc equations. Biases in SEs and CIs for effect sizes obtained with them are ignorable and point estimates of d and GMA d are the same whether obtained directly from the software or with post hoc equations.
引用
收藏
页码:96 / 111
页数:16
相关论文
共 50 条
  • [31] Adverse Effects of Esketamine for the Treatment of Major Depression Disorder: Findings from Randomized Controlled Trials
    Siyuan Yang
    Jiahe Wang
    Xiang Li
    Tianyi Wang
    Zhongmou Xu
    Xiang Xu
    Xinmin Zhou
    Gang Chen
    Psychiatric Quarterly, 2022, 93 : 81 - 95
  • [32] Efficacy and adverse effects of memantine treatment for Alzheimer's disease from randomized controlled trials
    Jiang, Jue
    Jiang, Hong
    NEUROLOGICAL SCIENCES, 2015, 36 (09) : 1633 - 1641
  • [33] Instrumental variable estimation of early treatment effect in randomized screening trials
    Saha, Sudipta
    Liu, Zhihui
    Saarela, Olli
    LIFETIME DATA ANALYSIS, 2021, 27 (04) : 537 - 560
  • [34] Machine learning for estimating individual treatment effects in randomized controlled trials
    Verstraete, Kenneth
    Das, Nilakash
    Gyselinck, Iwein
    De Vos, Maarten
    Janssens, Wim
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [35] Instrumental variable estimation of early treatment effect in randomized screening trials
    Sudipta Saha
    Zhihui Liu
    Olli Saarela
    Lifetime Data Analysis, 2021, 27 : 537 - 560
  • [36] Effects of moxibustion for constipation treatment: a systematic review of randomized controlled trials
    Lee M.S.
    Choi T.-Y.
    Park J.-E.
    Ernst E.
    Chinese Medicine, 5 (1)
  • [37] An Investigation of Potential Treatment Effect Modifiers in Multiple Myeloma from Published Randomized Controlled Trials
    He, Jianming
    Chiang, Karen
    Lin, Xiwu
    Maringwa, John
    Yang, Lingfeng
    Kwong, Jackie
    Nair, Sandhya
    Hashim, Mahmoud
    Samjoo, Imtiaz
    BLOOD, 2024, 144 : 7827 - 7828
  • [38] Hierarchical Bayes Approach to Estimate the Treatment Effect for Randomized Controlled Trials
    Liang, Xinya
    Kamata, Akihito
    Li, Ji
    EDUCATIONAL AND PSYCHOLOGICAL MEASUREMENT, 2020, 80 (06) : 1090 - 1114
  • [39] Accounting for unequal cluster sizes in designing cluster randomized trials to detect treatment effect heterogeneity
    Tong, Guangyu
    Esserman, Denise
    Li, Fan
    STATISTICS IN MEDICINE, 2022, 41 (08) : 1376 - 1396
  • [40] Targeted Maximum Likelihood Estimation for Dynamic Treatment Regimes in Sequentially Randomized Controlled Trials
    Chaffee, Paul H.
    van der Laan, Mark J.
    INTERNATIONAL JOURNAL OF BIOSTATISTICS, 2012, 8 (01):